Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Current Assets:    
Cash $ 1,625,241 $ 8,224,508
Prepaid expenses and other current assets 3,021,905 2,976,583
Total Current Assets 4,647,146 11,201,091
Intangible assets, net 1,710,562 1,948,913
In-process research and development 12,410,854 12,575,780
Goodwill 34,588,951 36,987,886
Total Assets 53,357,513 62,713,670
Current Liabilities:    
Accounts payable 1,590,530 586,611
Accrued expenses 1,879,806 1,964,580
Accrued expenses - related parties 103,494 18,370
Loans payable - current portion 803,917 1,828,079
Loans payable - related parties 85,398 81,277
Derivative liabilities 2,502,715 15,220,367
Total Current Liabilities 6,965,860 19,699,284
Loans payable - non current portion 37,343 48,165
Deferred tax liability 3,562,886 3,643,526
Total Liabilities 10,566,089 23,390,975
Commitments and contingencies (Note 8)
Stockholders’ Equity:    
Preferred stock, $0.0001 par value; 5,000,000 shares authorized; (see designations and shares authorized for Series A, Class C and Class K preferred stock)
Class C Preferred Stock; 1 share authorized, issued and outstanding at June 30, 2022 and December 31, 2021
Class K Preferred Stock; 1 share authorized, issued and outstanding at June 30, 2022 and December 31, 2021
Common stock, $0.0001 par value; 100,000,000 shares authorized; 34,143,823 and 34,035,925 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively 3,414 3,404
Additional paid-in capital 108,785,991 107,184,137
Accumulated other comprehensive income (1,818,692) 817,440
Accumulated deficit (64,179,289) (68,682,286)
Total Stockholders’ Equity 42,791,424 39,322,695
Total Liabilities and Stockholders’ Equity $ 53,357,513 $ 62,713,670